Hôpital Franco-Britannique-Fondation Cognacq-Jay
4 clinical trials · Sponsor
◉ Watch Hôpital Franco-Britannique-Fondation Cognacq-Jay
| Record | Firm | Date |
|---|---|---|
| TWICE-IRI: Optimization of Second-line Therapy With Aflibercept, Irinotecan (Day 1 or Day 1,3), 5-Fluorouracile and Folinic Acid in Patients With Metastatic Colorectal Cancer. A Randomized Phase III Study. (NCT04392479) | Hôpital Franco-Britannique-Fondation Cognacq-Jay | 2020-09-02 |
| Cetuximab as Salvage Therapy in Patients With Neo Wild-type RAS/RAF Metastatic Colorectal Cancer With Liver Metastases. (NCT04189055) | Hôpital Franco-Britannique-Fondation Cognacq-Jay | 2020-01-07 |
| Incidence and Risk Factors of Prolonged Grief in Palliative Care Units (NCT03748225) | Hôpital Franco-Britannique-Fondation Cognacq-Jay | 2019-02-04 |
| HIV-1 Infected Adult Subjects With HIV-associated Neurocognitive Disorders Despite Effective Antiretroviral Therapy (NCT04266002) | Hôpital Franco-Britannique-Fondation Cognacq-Jay | 2011-11-01 |
Track Hôpital Franco-Britannique-Fondation Cognacq-Jay automatically
Every clearance here is in the API, with alerts when new ones post.